Sciencast Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,315
Closed -$210K 422
2023
Q3
$210K Buy
+11,315
New +$264K 0.1% 286
2022
Q2
Sell
-7,961
Closed -$529K 654
2022
Q1
$529K Sell
7,961
-20,370
-72% -$1.47M 0.12% 229
2021
Q4
$2.53M Buy
28,331
+14,933
+111% +$1.78M 0.44% 80
2021
Q3
$1.81M Buy
+13,398
New +$1.95M 0.51% 64
2021
Q2
Sell
-9,111
Closed -$1.69M 693
2021
Q1
$1.69M Buy
+9,111
New +$2.11M 0.34% 90
2020
Q3
Sell
-7,117
Closed -$1.49M 540
2020
Q2
$1.49M Buy
7,117
+3,425
+93% +$600K 0.37% 84
2020
Q1
$587K Buy
+3,692
New +$430K 0.16% 89

Other funds holding TDOC

Sciencast Management's TDOC Position: Q4 2023 in Review

Sciencast Management sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 11,315 shares — an estimated $210K sold.

Sciencast Management first reported a position in TDOC in Q1 2020 and held it in 7 quarters. The position peaked at $2.53M in Q4 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Sciencast Management reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Sciencast Management sold 11,315 Teladoc Health shares in Q4 2023, an estimated $210K.
  • Sciencast Management first reported a position in Teladoc Health in Q1 2020 and held it in 7 quarters.
  • Sciencast Management's Teladoc Health position peaked at $2.53M in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Sciencast Management's 13F filing for Q4 2023, filed 14 Feb 2024.